0001681648-20-000002.txt : 20200724 0001681648-20-000002.hdr.sgml : 20200724 20200724103236 ACCESSION NUMBER: 0001681648-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200724 DATE AS OF CHANGE: 20200724 EFFECTIVENESS DATE: 20200724 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Providence Therapeutics Inc. CENTRAL INDEX KEY: 0001681648 IRS NUMBER: 000000000 STATE OF INCORPORATION: A0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-371761 FILM NUMBER: 201045589 BUSINESS ADDRESS: STREET 1: 140 SUNHAVEN CLOSE SE CITY: CALGARY STATE: A0 ZIP: T2X 2V9 BUSINESS PHONE: 403-909-4532 MAIL ADDRESS: STREET 1: 140 SUNHAVEN CLOSE SE CITY: CALGARY STATE: A0 ZIP: T2X 2V9 D 1 primary_doc.xml X0708 D LIVE 0001681648 Providence Therapeutics Inc. 140 SUNHAVEN CLOSE SE CALGARY A0 ALBERTA, CANADA T2X 2V9 403-909-4532 ALBERTA, CANADA None None Corporation true 2015 Bradley Sorenson 140 Sunhaven Close SE Calgary A0 ALBERTA, CANADA T2X 2V9 Executive Officer Director Scott Leary 14232 Caminito Vistana San Diego CA CALIFORNIA 92130 Executive Officer Director Eric Marcusson 239 Brannan Street #8J San Francisco CA CALIFORNIA 94107 Executive Officer Darlene Haslam 28 Oki Drive NW Calgary A0 ALBERTA, CANADA T3B6A8 Executive Officer Natalia Orozco MaRS Centre, West Tower, 661 University Suite 1300 Toronto A6 ONTARIO, CANADA M5G0B7 Executive Officer Kenneth Hughes 229 Emerald Bay Drive Calgary A0 ALBERTA, CANADA T3Z3G1 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2018-12-01 false true true false 0 1000001 1000001 0 false 2 0 0 0 false Providence Therapeutics Inc. Bradley Sorenson Bradley Sorenson Chief Executive Officer 2020-07-23